Single-blind randomized trial of combination antibiotic therapy in rheumatoid arthritis

Journal of Rheumatology

Volumn 33, Issue 2, 2006, Pages 224-227

  Gompels, Luke L ^a   Smith, Angela ^b   Charles, Peter J ^a   Rogers, Wendy ^a   Soon Shiong, Joanne ^a   Mitchell, Adam ^a   Doré, Caroline ^c   Taylor, Peter W ^a   Mackworth Young, Charles G ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Other Disease Group Statistics

Author keywords

Antibiotic; Rheumatoid arthritis; Therapy

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; PLACEBO; TETRACYCLINE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; JOINT SWELLING; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SINGLE BLIND PROCEDURE;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; ARTHRITIS, RHEUMATOID; CHLORTETRACYCLINE; CLINDAMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HEALTH STATUS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PILOT PROJECTS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 32144435726     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Brooks PM. Treatment of rheumatoid arthritis: from symptomatic relief to potential cure. Br J Rheumatol 1998;37:1265-71.
2. O'Dell JR. Therapeutic strategies for rheumatoid arthritis. N Engl J Med 2004;350:2591-602.
3. Olsen NJ, Stein CM. New drugs for rheumatoid arthritis. N Engl J Med 2004;350:2167-79.
4. Wolfe F, Hawley DJ, Cathey MA. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts. J Rheumatol 1990;17:994-1002.
5. Brown TM, Bush SW, Felts WR. Management of the chronically ill patient. In: Wohe MG, editor. Long term illness. Philadelphia: WB Saunders; 1959.
6. Ford DK. The microbiological causes of rheumatoid arthritis. J Rheumatol 1991;18:1441-2.
7. Skinner M, Cathcart ES, Mills JA, Finals RS. Tetracycline in the treatment of rheumatoid arthritis. Arthritis Rheum 1971;14:727-32.
8. Kloppenburg M, Breedveld FC, Terwiel JP, Mallee C, Dijkmans BA. Minocycline in active rheumatoid arthritis. A double-blind, placebo controlled trial. Arthritis Rheum 1994;37:629-36.
9. Tilley BC, Alarcon GS, Heyse SP, et al. Minocycline in rheumatoid arthritis. A 48 week, double blind, placebo controlled trial. MIRA Trial group. Ann Intern Med 1995;122:81-9.
10. O'Dell JR, Haire CE, Palmer W, et al. Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1997;40:794-6.
11. O'Dell JR, Blakely KW, Mallek JA, et al. Treatment of early seropositive rheumatoid arthritis: a two year, double blind comparison of minocycline and hydroxychloroquine. Arthritis Rheum 2001;44:2235-41.
12. Basler RS. Minocycline-related hyperpigmentation. Arch Dermatol 1985;121:606-8.
13. Pruzanski W, Greenwald RA, Street IP, et al. Inhibition of enzymatic activity of phospholipase A2 by minocycline and doxycycline. Biochem Pharmacol 1992;44:1165-70.
14. ElAttar TM, Lin HS, Shultz R. Effect of minocycline on prostaglandin formation in gingival fibroblasts. J Periodontal Res 1988;23:285-6.
15. Golub LM, McNamara TF, D'Angelo G, et al. A non antibacterial chemically modified tetracycline inhibits mammalian collagenase activity. J Dent Res 1987;66:1310-4.
16. Van Barr HM, van de Kerkhof PC, Mier PD, Happle R. Tetracyclines are potent scavengers of the superoxide radical [letter]. Br J Dermatol 1987;117:131-2.
17. Amin AR, Attur MG, Thakker GD, et al. A novel mechanism of action of tetracylines: effect on nitric oxide synthetases. Proc Natl Acad Sci USA 1996;93:14014-9.
18. Gabler WL, Creamer HR. Suppression of human neutrophil functions by tetracyclines. J Peridontal Res 1991;26:52-8.
19. Vincenti MP, Clark IM, Brinckerhoff CE. Using inhibitors of metalloproteinase to treat arthritis. Arthritis Rheum 1994;37:1115-26.
20. Warner GT, Plosker GL. Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne. Am J Clin Dermatol 2002;3:349-60.
21. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
22. Felson DT, Anderson JJ, Boers M, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
23. Van der Heijde D. Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability. Baillieres Clin Rheumatol 1996;10:435-53.
24. Kloppenburg M, Verweij CL, Miltenburg AM. The influence of tetracyclines on T cell activation. Clin Exp Immunol 1995;102:635-41.
25. Gaston JSH. The involvement of the gut in pathogenesis of inflammatory synovitis. Br J Rheumatol 1998;41:1548-51.